Sarepta Therapeutics SRPT reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Sarepta Therapeutics beat estimated earnings by 31.86%, reporting an EPS of $-0.77 versus an estimate of $-1.13.
Revenue was up $56.32 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.7 which was followed by a 0.51% increase in the share price the next day.
Here's a look at Sarepta Therapeutics's past performance:
Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
---|---|---|---|---|
EPS Estimate | -1.89 | -1.29 | -1.78 | -1.77 |
EPS Actual | -0.19 | -1.52 | -1.54 | -1.84 |
Revenue Estimate | 173.42M | 162.64M | 143.33M | 146.29M |
Revenue Actual | 189.41M | 164.09M | 146.93M | 145.14M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.